NCT01447095View on ClinicalTrials.gov

Effects of Prostacyclin Infusion on Cerebral Vessels and Metabolism in Patients With Subarachnoid Haemorrhage

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Subarachnoid Hemorrhage
Interventions
DRUG

Prostacyclin 1 ng/kg/min

Continuous i.v. infusion of epoprostenol 1 ng/kg/min day 5-10 after SAH

DRUG

Prostacyclin 2 ng/kg/min

Continuous i.v. infusion of epoprostenol 2 ng/kg/min day 5-10 after SAH

DRUG

Placebo

Continuous i.v. infusion with placebo day 5-10 after SAH

Trial Locations (1)

2200

Rigshospitalet, dep. of neurosurgery, Copenhagen

All Listed Sponsors
lead

Rune Rasmussen

OTHER

NCT01447095 - Effects of Prostacyclin Infusion on Cerebral Vessels and Metabolism in Patients With Subarachnoid Haemorrhage | Biotech Hunter | Biotech Hunter